Advertisement
Advanced Search

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

Glycemia is a crucial laboratory parameter; and from a “therapeutic” point of view, it is essential to avoid/correct both hypoglycemia and hyperglycemia, particularly if they are pronounced. This also holds true for patients with acute myocardial infarction (AMI). Indeed, in addition to general principles, one of the reasons why correction of high/low glycemia is important in AMI comes from precise investigations of prognostic impact of dysglycemia in this diasease.

To access this article, please choose from the options below

Log In


Forgot password?

Register

Create a new account

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

The author would like to thank Vesna Milovanovic, MD, Canterbury, UK, for the scientific edit of the manuscript.

☆☆This work has been supported by the Serbian Ministry of Education and Science (Belgrade, Serbia), grant no. III41018 .

Related Articles

Searching for related articles..

Advertisement